← Open Payments lookup

MEHANDAR KUMAR: Open Payments

NPI 1790082550 · KEANSBURG, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$659 in 30 payments from 17 companies in 2025. Trend: 2023 $995 · 2024 $978 · 2025 $659

Food & beverage: $659
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.4$172
Janssen Biotech, Inc.5$84
Eisai Inc.3$60
GlaxoSmithKline, LLC.3$58
AstraZeneca Pharmaceuticals LP2$34
TAIHO ONCOLOGY, INC.2$31
ABBVIE INC.1$30
Aveo Pharmaceuticals, Inc.1$23
Novartis Pharmaceuticals Corporation1$23
Genentech USA, Inc.1$21

Products named: OPDIVO, Lenvima, VENCLEXTA, OJJAARA, ERLEADA, LONSURF, FOTIVDA, Fabhalta.

Industry payments across NJ — which companies pay providers there.